Buyer Mistakes · Fertility Clinic

Don't Let These Mistakes Derail Your Fertility Clinic Acquisition

From physician dependency to SART data gaps, here are the six mistakes that sink fertility clinic deals — and how to avoid every one.

Find Vetted Fertility Clinic Deals

Fertility clinic acquisitions trade at 5–9x EBITDA and carry unique risks rooted in physician concentration, regulatory complexity, and publicly reported outcome data. Buyers who skip specialized due diligence routinely overpay or inherit liabilities that erode returns within 12 months of close.

Common Mistakes When Buying a Fertility Clinic Business

critical

Underestimating Single-Physician Dependency Risk

Many fertility clinics generate 90%+ of revenue through one reproductive endocrinologist. If that physician leaves post-close without a strong employment agreement and earnout structure, patient volume can collapse within 90 days.

How to avoid: Require a 3–5 year physician employment agreement with non-compete before closing. Structure 15–25% of purchase price as an earnout tied to patient retention and EBITDA performance post-transition.

critical

Ignoring SART and CDC ART Outcome Data

Publicly reported SART success rates are the primary driver of patient acquisition in fertility. Buyers who skip benchmarking a clinic's live birth rates against national averages miss the most important brand and revenue risk factor in the deal.

How to avoid: Pull three years of SART and CDC ART reports before LOI. Compare per-transfer live birth rates against national and regional averages. Below-average rates signal patient attrition risk post-acquisition.

major

Overlooking IVF Laboratory Equipment Age and Condition

An outdated IVF laboratory with aging incubators, micromanipulation systems, or vitrification equipment can require $500K–$1.5M in immediate capital replacement — costs rarely reflected in seller asking prices.

How to avoid: Commission an independent embryology laboratory audit before closing. Document equipment age, maintenance records, and remaining useful life. Factor replacement costs directly into your purchase price negotiation.

critical

Failing to Validate the Corporate Practice of Medicine Structure

Most states prohibit non-physicians from owning medical practices outright. Buyers who acquire a fertility clinic without a properly structured MSO and Professional Services Agreement risk regulatory violations that can void the acquisition entirely.

How to avoid: Engage healthcare counsel with state-specific CPOM expertise before LOI. Confirm the MSO structure is compliant and that physician-owned PC agreements are properly documented and transferable.

major

Accepting Seller Financial Statements Without a Quality of Earnings Report

Fertility clinic P&Ls frequently include above-market physician compensation, personal expenses, and one-time revenue items that inflate stated EBITDA. Paying 7x on inflated earnings is a fast path to a failed deal.

How to avoid: Require a third-party Quality of Earnings report normalizing physician compensation to market rates and removing non-recurring items. Never base purchase price on seller-prepared financials alone.

major

Misreading Payer Mix and Insurance Reimbursement Trends

A clinic heavily reliant on a single employer fertility benefit contract or state mandate reimbursement faces revenue concentration risk. Policy changes or contract non-renewals can eliminate 30–40% of revenue overnight.

How to avoid: Analyze three years of payer mix data. Confirm employer and Progyny or WINFertility contract terms, renewal dates, and exclusivity clauses. Prioritize clinics with diversified self-pay and multi-payer revenue.

Warning Signs During Fertility Clinic Due Diligence

  • Seller refuses to provide SART data or CDC ART outcome reports for the past three reporting cycles
  • No associate reproductive endocrinologist on staff and founding physician is over age 60 with no succession plan
  • IVF laboratory equipment is more than 8 years old with no documented preventive maintenance program
  • Clinic legal structure does not include a properly documented MSO and Professional Services Agreement
  • Multiple unresolved patient complaints, active malpractice claims, or a prior CDC adverse inspection finding on record

Frequently Asked Questions

Are fertility clinics eligible for SBA financing?

No. Fertility clinics are not SBA-eligible due to their medical practice classification. Buyers typically use private equity capital, seller financing, or healthcare-focused lenders to fund acquisitions.

What EBITDA multiple should I expect to pay for a SART-member fertility clinic?

Established SART-member clinics with above-average success rates and multiple REs trade at 6–9x EBITDA. Single-physician clinics with average outcomes typically command 5–6x given higher transition risk.

How does an MSO structure protect a fertility clinic buyer?

An MSO allows a non-physician entity to own management and operational assets while a physician-owned PC retains clinical control, maintaining compliance with state corporate practice of medicine laws.

What due diligence is most commonly skipped in fertility clinic acquisitions?

Buyers most often skip embryology lab audits and HIPAA compliance reviews of embryo disposition consents — two areas that can generate significant post-close liability if overlooked during diligence.

More Fertility Clinic Guides

Find Fertility Clinic deals the right way

DealFlow OS helps you find and evaluate acquisitions with seller signals and due diligence tools. Free to join.

Start finding deals — free

No credit card required